I am honored to have been invited to speak on behalf of the innovative pharmaceutical industry at the launch of the new Global Diabetes Compact on 14 April 2021. The Global Diabetes Compact is being launched at an important time in history of diabetes. 100 years ago, the discovery of insulin in 1921 kicked off...
Read moreOn 9 April 2021, I participated in very lively debate hosted by Intelligence Squared, and moderated by John Donvan, Putlizer Prize Finalist and America’s best recognized moderator of live event debate and four-time Emmy Award winner. I agreed to disagree with Brook Baker, Professor of Law, Northeastern University School of Law on the future of...
Read moreSpeech Thomas Cueni, Director General, IFPMA 13 April 2021 Good morning. “I have three main messages for you today: First, we hear you, and we are sensitive to the debate about cost and pricing. Second, we are seeing great transformative new treatments reaching patients, and we are making progress through new partnerships in reaching many...
Read moreGeneva, 9 April 2021 – We commend COVAX on the launch of its Web Portal for the no-fault compensation program (NFC) for the 92 low- and middle-income countries eligible for support under the COVAX Advance Market Commitment (AMC). The development of this international NFC system is a historic achievement, and the program will play a...
Read more30 March 2021 – In view of the social and economic impact of current COVID-19 crisis, political leadership in preparing for any eventual future pandemic is crucial. Over the last 12 months we have seen the importance of a strong innovation system and the successful development of several safe and highly effective vaccines in record...
Read moreIn this paper, we will be focusing on medicinal products (medicines, including biologics and vaccines), though many of these principles can be applied to medical devices.
Read moreIncreasing manufacturing capacity for COVID-19 vaccines is one of the biggest challenges we need to address in our common goal to bring this pandemic to an end. Science has delivered not one but several vaccines that are safe and effective and the goal is ensure fair and equitable delivery to vaccines to those who most...
Read more2020 witnessed a decade of scientific progress compressed into just 12 months. And as a result we now have, ahead of all predictions, a number of C-19 vaccines that can protect the heroic healthcare workers, the elderly and the vulnerable; and hopefully society as a whole as long as we can keep the mutations in...
Read moreThis blog was originally published on Media Planet Infectious Disease campaign on 24 March 2021. Whilst we are still in the midst of COVID-19, the worst pandemic since 1918 which is affecting every part of our lives, we can draw some lessons that will allow us to be better prepared for the future. The first...
Read moreA summit was convened in a matter of weeks by Chatham House, in collaboration with COVAX, IFPMA, DCVMN, and BIO, took place on 8-9 March 2021. A discussion document helped inform participants, gave an overview of the current COVID-19 vaccine manufacturing supply chain and identified emerging challenges. While the meeting was conducted under Chatham House rule to facilitate an...
Read more